Early use of chemotherapy in metastatic prostate cancer

scientific article

Early use of chemotherapy in metastatic prostate cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CTRV.2016.09.017
P698PubMed publication ID27720577

P50authorMichael A. CarducciQ114718060
P2093author name stringMark C Markowski
P921main subjectprostate cancerQ181257
P304page(s)218-224
P577publication date2016-10-03
P13046publication type of scholarly workreview articleQ7318358
P1433published inCancer Treatment ReviewsQ1955762
P1476titleEarly use of chemotherapy in metastatic prostate cancer
P478volume55

Reverse relations

cites work (P2860)
Q60046568Cost-effectiveness analyses and cost analyses in castration-resistant prostate cancer: A systematic review
Q47413250Functional analysis of Cullin 3 E3 ligases in tumorigenesis.
Q41488394Low TIM3 expression indicates poor prognosis of metastatic prostate cancer and acts as an independent predictor of castration resistant status
Q58692138Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy: Treatment Patterns From the PROXIMA Prospective Registry
Q42353513Treatment of metastatic prostate cancer after STAMPEDE.

Search more.